Find Faculty

Saurabh Mehandru, MD

img_Saurabh Mehandru
PROFESSOR | Medicine, Gastroenterology
PROFESSOR | Immunology & Immunotherapy
email
Are you a patient?
View my
Provider Profile
Specialties
Gastroenterology
Research Topics
AIDS/HIV, Aging, Antigen Presentation, Autoimmunity, B Cells, Cell Adhesion, Cell Biology, Cellular Immunity, Chemokines, Cytokines, Dendritic Cells, Epithelial Cells, Gene Expressions, Hepatitis C Virus, Immune Deficiency, Immunology, Immunosuppression, Infectious Disease, Inflammation, Integrins, Knockout Mice, Lung, Lymphocytes, Macrophage, Microarray, Mucosal Immunology, Retinoic Acid, Retrovirus, T Cells, Trafficking
Multi-Disciplinary Training Area
Immunology [IMM]

MD, University College of Medical Sciences-Delhi

Residency, Psychiatry, University of Delhi

Residency, Internal Medicine, Bellevue Hospital Center

Fellowship, Gastroenterology, Mount Sinai Hospital

Certifications

American Board of Internal Medicine
113
Publications

Selected Publications

IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens. Roser Tachó-Piñot, Habib Bashour, Martyna Filipska, Celia Corral-Vazquez, Mauricio Guzman, Xavi Marcos-Fa, Donata Martinuzzi, Hannah Honner, Pablo Canales Herrerias, Sonia Tejedor Vaquero, Alba Sáez Gordón, Julia Perera-Bel, Jorge Domínguez Barragán, Berta Arcos-Ribas, Leire de Campos-Mata, Andrei Slabodkin, Maria Chernigovskaya, Maria Luisa Rodríguez de la Concepción, Jose Gutierrez-Marcos, Ana García-García, Andres Nascimento Osorio, Mariona Pascal, Jordi Yagüe, Manel Juan, Juan Ignacio Aróstegui, Rafael Hijano Esqué, Albert Sánchez Font, Stephan Ehl, Bodo Grimbacher, Marta Rizzi, Laura Dotta, Kang Chen, Raffaele Badolato, Laia Alsina, Saurabh Mehandru, Charlotte Cunningham-Rundles, Jorge Carrillo, Giuliana Magri, Victor Greiff, Andrea Cerutti. Journal of Experimental Medicine

B Cell Dysregulation in IBD: From Pathophysiology to Therapeutic Targeting. Divya Jha, Saurabh Mehandru. Inflammatory Bowel Diseases

Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart. Jeffrey Downey, Ana Oliveira-Coelho, M. G. Kiss, Gabriel Laghlali, Alexander Leunig, Emir Radkevich, Laszlo Halasz, Martin Umali, Joana Ferreira da Silva, Madeline L. Eller, Matteo Gianeselli, Magdalena M. Żak, Haley E. Randolph, Gabriel Caumartin, Wolfram C. Poller, Henrike Janssen, Laura L. Koekkoek, Jamshid Abdul-Ghafar, Pacific Huynh, Darwin D’Souza, Vladimir Roudko, Sheqouia Nauta, Jazz Munitz, Xisheng Li, Thomas Rathner, Ziche Chen, Anh Phan, Abigail Glick, Katarzyna Cialowicz, Zhihong Chen, Seunghee Kim-Schulze, Seonghun Yoon, Matthias Nahrendorf, Susmita Sahoo, Miriam Merad, Adolfo García-Sastre, Cameron S. McAlpine, Gustav J. Strijkers, Viviana Simon, Rachel Brody, Saurabh Mehandru, Zahi A. Fayad, Benjamin P. Kleinstiver, Lior Zangi, Mandy M.T. van Leent, Michael Schotsaert, Filip K. Swirski. Immunity

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Mehandru during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bristol-Myers Squibb
  • Genentech, Inc.
  • Adacyte Therapeutics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.